DK0610286T3 - Rekombinante immunotoxiner - Google Patents

Rekombinante immunotoxiner

Info

Publication number
DK0610286T3
DK0610286T3 DK92921866T DK92921866T DK0610286T3 DK 0610286 T3 DK0610286 T3 DK 0610286T3 DK 92921866 T DK92921866 T DK 92921866T DK 92921866 T DK92921866 T DK 92921866T DK 0610286 T3 DK0610286 T3 DK 0610286T3
Authority
DK
Denmark
Prior art keywords
recombinant immunotoxins
immunotoxins
recombinant
relates
pe38kdel
Prior art date
Application number
DK92921866T
Other languages
English (en)
Inventor
David Fitzgerald
Uli Brinkmann
Lee Pai
Mark Willingham
Ira Pastan
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0610286T3 publication Critical patent/DK0610286T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92921866T 1991-09-30 1992-09-29 Rekombinante immunotoxiner DK0610286T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76733191A 1991-09-30 1991-09-30
PCT/US1992/008257 WO1993007286A1 (en) 1991-09-30 1992-09-29 Recombinant immunotoxins

Publications (1)

Publication Number Publication Date
DK0610286T3 true DK0610286T3 (da) 2000-07-17

Family

ID=25079156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92921866T DK0610286T3 (da) 1991-09-30 1992-09-29 Rekombinante immunotoxiner

Country Status (8)

Country Link
EP (1) EP0610286B1 (da)
JP (1) JP3512795B2 (da)
AT (1) ATE190659T1 (da)
AU (1) AU675413B2 (da)
CA (1) CA2120153C (da)
DE (1) DE69230798T2 (da)
DK (1) DK0610286T3 (da)
WO (1) WO1993007286A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889157A (en) * 1990-10-12 1999-03-30 The United States Of America As Represented By The Department Of Health And Human Services Humanized B3 antibody fragments, fusion proteins, and uses thereof
US5981726A (en) * 1990-10-12 1999-11-09 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof
US5608039A (en) * 1990-10-12 1997-03-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Single chain B3 antibody fusion proteins and their uses
EP0654085B1 (en) * 1992-01-23 1997-04-02 MERCK PATENT GmbH Monomeric and dimeric antibody-fragment fusion proteins
PT651805E (pt) * 1992-07-17 2007-02-28 Dana Farber Cancer Inst Inc Método de ligação intracelular de moléculas-alvo
US5747654A (en) * 1993-06-14 1998-05-05 The United States Of America As Represented By The Department Of Health And Human Services Recombinant disulfide-stabilized polypeptide fragments having binding specificity
FR2706486B1 (fr) * 1993-06-16 1995-09-01 Rhone Poulenc Rorer Sa Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.
US5851829A (en) * 1993-07-16 1998-12-22 Dana-Farber Cancer Institute Method of intracellular binding of target molecules
AU717611B2 (en) * 1994-10-28 2000-03-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Tumor-specific antibody fragments, fusion proteins, and uses thereof
WO1996038571A2 (en) * 1995-05-31 1996-12-05 Regents Of The University Of Minnesota Recombinant polypeptide cytotoxins for cancer treatment
DE69629580D1 (de) * 1995-10-13 2003-09-25 Us Gov Health & Human Serv Immunotoxin enthaltend ein disulfid-stabilisiertes antikörperfragment
WO1997044461A2 (en) 1996-05-22 1997-11-27 Novopharm Biotech, Inc. Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
BR9712900A (pt) 1996-11-06 2000-11-28 Univ California Enzima liberadora de receptor de fator de necrose de tumor isolado, composições que compreendem a enzima e métodos de utilização da mesma
US7115722B1 (en) 1997-05-22 2006-10-03 Viventia Biotech, Inc. Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
JP3471006B2 (ja) 1998-05-20 2003-11-25 中外製薬株式会社 新規な遺伝子クローニング方法
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
JP2009520468A (ja) * 2005-12-23 2009-05-28 ヴィヴェンティア バイオテック インコーポレーティッド 融合タンパク質ライブラリーの作製法およびスクリーニング法、ならびにそれらの使用
US8932586B2 (en) 2011-09-06 2015-01-13 Intrexon Corporation Modified forms of Pseudomonas exotoxin A

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE138688T1 (de) * 1989-04-21 1996-06-15 Us Health Rekombinantes antikörper-toxin-fusion-protein

Also Published As

Publication number Publication date
EP0610286A4 (en) 1995-10-25
DE69230798T2 (de) 2000-08-03
EP0610286B1 (en) 2000-03-15
CA2120153C (en) 2006-06-06
DE69230798D1 (de) 2000-04-20
ATE190659T1 (de) 2000-04-15
JPH07502643A (ja) 1995-03-23
JP3512795B2 (ja) 2004-03-31
AU2779892A (en) 1993-05-03
AU675413B2 (en) 1997-02-06
EP0610286A1 (en) 1994-08-17
CA2120153A1 (en) 1993-04-15
WO1993007286A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
ATE190659T1 (de) Rekombinante immuntoxine
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
FI844510L (fi) Ensym-resistenta immunsystemet modulerande peptider.
FR2657259B1 (da)
ES2066603T3 (es) Fungicidas de 3-difluorometilpirazolcarboxamida.
BR0112111A (pt) Realce de respostas imunes mediadas por proteìna de fusão de anticorpo-citocina por tratamento combinado com agentes de realce de captação de imunocitocina
ES8602768A1 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
DE122006000010I2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in derBehandlung von kardiovaskularen Krankheiten
FI73995B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl- norskopinetrar.
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
GR3026219T3 (en) Mouse monoclonal antibodies
DE69434384D1 (de) Metalkomplexbildner
ATE199167T1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
DK0563085T3 (da) Hidtil ukendte præparater
EP0311616A4 (en) COMBINATION OF GAMMA INTERFERON AND ANTI-FLAMMING AGENTS OR ANTIPYRETIC AGENTS FOR THE TREATMENT OF DISEASES.
DE69106361T2 (de) Einschlusskomplex von nimesulide mit cyclodextrinen.
DK1431391T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
FI961339A (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
SE8900564D0 (sv) Novel medicinal use
ITMI911597A1 (it) Composizione di trattamento di acque di rifiuto da destinare al riciclo, e procedimento di riciclo di acque di rifiuto che utilizza questa composizione.
ITFE930013U1 (it) Bacchette orientali meccanizzate.
IT8459312V0 (it) Massaggiatore manuale in fibra intrecciata di tipo perfezionato.